LIA
NVO

Limestone Investment Advisors’s Novo Nordisk NVO Stock Holding History

Limestone Investment Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.08M Buy
111,100
+48,800
+78% +$2.31M 0.33% 49
2025
Q4 		$3.17M Buy
62,300
+51,400
+472% +$2.63M 0.3% 63
2025
Q3 		$605K Buy
10,900
+1,500
+16% +$87.8K 0.05% 251
2025
Q2 		$649K Buy
+9,400
New +$639K 0.06% 225

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Limestone Investment Advisors's NVO Position: Q1 2026 in Review

Limestone Investment Advisors increased its Novo Nordisk (NVO) stake by 119% in Q1 2026, buying an estimated $1.46M and bringing the position to 56,510 shares worth $2.08M. The position accounts for 0.17% of the portfolio, ranked #101.

Limestone Investment Advisors first reported a position in NVO in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.1M in Q3 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Limestone Investment Advisors held 56,510 shares of Novo Nordisk worth $2.08M as of Q1 2026.
  • Limestone Investment Advisors bought 30,733 Novo Nordisk shares in Q1 2026, an estimated $1.46M.
  • Novo Nordisk made up 0.17% of Limestone Investment Advisors's portfolio in Q1 2026, its #101 holding.
  • Limestone Investment Advisors first reported a position in Novo Nordisk in Q2 2025 and has held it in 4 quarters since.
  • Limestone Investment Advisors's Novo Nordisk position peaked at $2.1M in Q3 2025.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Limestone Investment Advisors's 13F filing for Q1 2026, filed 15 May 2026.